Showing results (1081-1090 of 1,109) with videos related to

Sort By:
Pageof 111
The Journal of Molecular Diagnostics : JMD|November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platformsMichèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter AnalysisArtur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Cancer Research|September 18, 2025
Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung CancerMelat T Gebru, Timothy E Hoffman, Aaron Boudreau, et al.
Cancers|July 27, 2024
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study GroupJoanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, et al.
Cancers|July 14, 2023
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of AgeAgata Tyczyńska, Marcela Krzysława Krzempek, Alexander Jorge Cortez, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Transplantation Proceedings|March 31, 2020
Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell TransplantAnna Waszczuk-Gajda, Jolanta Małyszko, David H Vesole, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Acta Haematologica|May 1, 2015
Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome RegistryKrzysztof Mądry, Rafał Machowicz, Anna Waszczuk-Gajda, et al.
Anticancer Research|July 5, 2020
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational StudyBartosz Pula, Elzbieta Iskierka-Jazdzewska, Monika Dlugosz-Danecka, et al.
Pageof 111